Funding for this research was provided by:
Natural Science Foundation of Hunan Province (2018JJ6100)
National Major Science and Technology Projects of China (2017ZXl0201101002009)
Received: 5 December 2019
Accepted: 5 March 2020
First Online: 17 March 2020
Ethics approval and consent to participate
: The research protocol, approved by the relevant institutional review boards or independent ethics committees, was conducted in accordance with standards for the protection of patient safety and welfare and in compliance with Good Clinical Practices and the principles of the Declaration of Helsinki and its amendments. According to “National Free AIDS ARV guidelines” (China), all participants who receive treatment from AIDS ARV supported by the Chinese government must have viral load testing and genotypic testing, which will be used for this study. Verbal informed consent is given to the doctors at the clinical sites who are responsible for the AIDS patients, and the patients’ names were kept on a list with the doctors’ signature. The study and the verbal consent procedure were approved by the Ethical Committee of Hunan Provincial Center for Disease Control and Prevention (ethical approval number: 201801).
: Not applicable.
: The authors declare that they have no competing interests.